AACC uses Cookies to ensure the best website experience. Continuing without changing Cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy

Putting SARS-CoV-2 Testing into Practice: Overcoming the Day-to-Day Challenges of Laboratorians and Infectious Disease Clinicians

  • Credit:1.0 ACCENT Credit
  • Duration: 1 hour
  • Date:NOV.18.2020 1:00 PM - 02:00 PM
  • Level: Intermediate

Price: $0.00

Member Price: $0.00

Register for this webinar, recorded November 18, 2020, to learn the latest information on how to overcome SARS-CoV-2 testing challenges. With your registration, you will have access to the recording on demand through November 30, 2021.

DESCRIPTION

Clinical laboratories have faced significant challenges responding to unprecedented demands for testing for SARS-CoV-2. These have included operational challenges related to supply chain, staffing and continuous demands for testing improvements. Due to its nature, fighting SARS-CoV-2 requires a diagnostics toolkit rather than a single solution during the various phases of the pandemic. Molecular, antigen detection and serological tests are now being deployed for number of different purposes. Recently the focus has shifted toward the desire to test asymptomatic population, utilize less invasive specimen types and establish testing protocols for coming respiratory virus season. In addition, the nuances of pre-symptomatic, pauci-symptomatic, and post-symptomatic detection of prolonged RNA shedding in SARS-CoV-2 have made the landscape of SARS-CoV-2 testing very difficult to negotiate for clinicians. Hear perspectives from a laboratory professional and infectious disease physician how to overcome these challenges, implement SARS-CoV-2 testing within different clinical scenarios and/or improve current protocols.

TARGET AUDIENCE

This activity is designed for lab supervisors, lab directors (and/or assistant directors), lab managers (supervisory and/or non-supervisory), point-of-care coordinators, and other laboratory professionals overseeing and/or carrying out SARS-CoV-2 testing.

LEARNING OBJECTIVES

At the end of this activity, participants will be able to:

  • Explain the operational challenges and successes laboratories have experienced responding to the unprecedented demands for diagnostic testing for SARS-CoV-2.
  • Summarize the roles of molecular, antigen and serological testing in the context of SARS-CoV-2 disease and efforts in development of commutable reference materials.
  • Describe recent changes in testing landscape, particularly in preparation for the coming respiratory season.
  • Explain the challenges in describing SARS-CoV-2 test performance to clinicians in the absence of a well-defined comparator gold standard.
  • Identify the evidence for and against asymptomatic SARS-CoV-2 infection as it pertains to testing of post-exposure, peri-operative, and other asymptomatic populations.

FACULTY

Scott Curry HeadshotScott R. Curry, MD
Assistant Professor and Infectious Disease Specialist
Medical University of South Carolina
Charleston, SC, USA

Frederick Nolte HeadshotFrederick S. Nolte, PhD, D(ABMM), F(AAM)
Professor and Vice Chair for Laboratory Medicine
Medical University of South Carolina
Charleston, SC, USA

DISCLOSURES AND STATEMENT OF INDEPENDENCE

AACC is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.

The following faculty reported the following financial relationship(s)

Scott R. Curry, MD
Grant/Research Support: Cepheid
Board/Committee Membership/Advisory Board: Ferring Pharmaceuticals

Frederick S. Nolte, PhD, D(ABMM), F(AAM)
Grant/Research Support: BioFire
Presenter/Speaker Honoraria: Abbott Molecular, Abbott, Roche, BioFire

The following planners reported no relevant financial relationship:
Nikolina Babic, PhD, DABCC, FAACC; Y. Victoria Zhang, PhD, MBA, DABCC, FAACC

CONTENT VALIDITY

All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; AND/OR All scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.

ACCREDITATION STATEMENT

This activity is approved for 1.0 ACCENT® continuing education credits. Activity ID# 2047. This activity was planned in accordance with ACCENT® Standards and Policies.

SUCCESSFUL COMPLETION STATEMENT

Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email [email protected].

Supported by

Ortho Clinical Diagnostics Logo